Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 168, Issue 1, pp 38–40 | Cite as

Permeability of Intestinal and Blood—Tissue Barriers in Rats for Evans Blue Dye under Conditions of Acute Intoxication with Cyclophosphamide

  • T. V. SchäferEmail author
  • Ju. Ju. Ivnitsky
  • V. L. Rejniuk
Article
  • 3 Downloads

Myeloablative therapy was modeled by administration of cyclophosphamide to rats in a dose of 2.1 LD50 for 14 days. Under these conditions, increased accumulation of Evans blue dye given by gavage was observed in the blood, brain, lung, liver, kidney, and ileum (by 34, 1.6, 149, 46, 30, and 6.2 times, respectively). After intravenous injection of the dye, its accumulation was increased only in the lung and ileum. Thus, simulation of myeloablation cytostatic therapy by cyclophosphamide injection to rats is associated with impairment of the intestinal and lung—blood barriers. These alterations predispose to penetration of biologically active substances from the small intestine, gastrointestinal chyme, and lungs to the blood, thus contributing to the development of the early toxic effects of cyclophosphamide.

Key Words

cyclophosphamide acute intoxication Evans blue intestinal barrier tissueblood barrier 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Legeza VI, Galeev ISh, Seleznev AB. Emetic Syndrome. St. Petersburg, 2005. Russian.Google Scholar
  2. 2.
    Rejniuk VL, Schäfer TV, Krasnov KA, Ivnitsky JJ. Effects of cyclophosphamide and lactulose on the release of ammonia and medium-molecular-weight substances from the intestine into blood in rats. Bull. Exp. Biol. Med. 2013;154(4): 460-463.CrossRefGoogle Scholar
  3. 3.
    Manual on Experimental (Preclinical) Study of New Pharmacological Substances, Khabriev RU, ed. Moscow, 2005. RussianGoogle Scholar
  4. 4.
    Brash JT, Ruhrberg C, Fantin A. Evaluating vascular hyperpermeability- inducing agents in the skin with the Miles assay. J. Vis. Exp. 2018;(136). doi: https://doi.org/10.379/57524Google Scholar
  5. 5.
    Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA. The potential for complete and durable response in nonglia primary brain tumors in children and young adults with enhanced chemotherapy delivery. Cancer J. Sci. Am. 1998;4(2):110-124.Google Scholar
  6. 6.
    Dore MP, Pes GM, Murino A, Quarta Colosso B, Pennazio M. Short article: small intestinal mucosal injury in patients taking chemotherapeutic agents for solid cancers. Eur. J. Gastroenterol. Hepatol. 2017;29(5):568-571.CrossRefGoogle Scholar
  7. 7.
    El-Kashef DH. Role of venlafaxine in prevention of cyclophosphamide- induced lung and airway hyperactivity in rats. Environ.Toxicol. Pharmacol. 2018;58:70-76.CrossRefGoogle Scholar
  8. 8.
    Fasslrinner F, Schetelig J, Burchert A, Kramer M, Trenschel R, Hegenbart U, Stadler M, Schäfer-Eckart K, Bätzel M, Eich H, Stuschke M, Engenhart-Cabillic R, Krause M, Dreger P, Neubauer A, Ehninger G, Beelen D, Berdel WE, Siepmann T, Stelljes M, Bornhäuser M. Long-term efficacy of reducedintensity versus myeloablative conditioning before allogenic haemopoietic cell transplantation in patients with acute myeloid laekaemia in first complete remission: retrospective follow-up open-label, randomized phase 3 trial. Lancet Haematol. 2018;5(4):e161-e169.CrossRefGoogle Scholar
  9. 9.
    Horn CC, Kimball BA, Wang H, Kaus J, Dienel S, Nagy A,Gathright GR, Yates BJ, Andrews PL. Why can’t rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS One. 2013;8(4). ID e60537. doi: https://doi.org/10.1371/journal. pone.0060537Google Scholar
  10. 10.
    Ivnitsky JJ, Rejniuk VL, Schäfer TV, Malakhovsky VN. Fulminant hyperammonaemia induced by thiopental coma in rats. Toxicology. 2006;224(3):184-190.CrossRefGoogle Scholar
  11. 11.
    Majzner RG, Mogri H, Varadhan R, Brown P, Cooke KR, Bolaños-Meade J, Swinnen L, Kanakry J, Luznik L, Jones RJ, Fuchs E, Ambinder R, Kasamon Y, Symons HJ. Post-transplantation cyclophosphamide after bone marrow transplantation is not associated with an increased risk of donor-derived malignancy. Biol. Blood Marrow Transplant. 2017;23(4):612-617.CrossRefGoogle Scholar
  12. 12.
    Schäfer TV, Ivnitsky JJ, Rejniuk VL. Cyclophosphamide-induced leakage of gastrointestinal ammonia into the common bloodstream in rats. Drug Chem. Toxicol. 2011;34(1):25-31.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • T. V. Schäfer
    • 1
    Email author
  • Ju. Ju. Ivnitsky
    • 2
  • V. L. Rejniuk
    • 2
  1. 1.State Research Test Institute of Military MedicineMinistry of Defense the Russian FederationSt. PetersburgRussia
  2. 2.Institute of ToxicologyFederal Medical- Biological Agency of RussiaSt. PetersburgRussia

Personalised recommendations